A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma

Clinical trial NCT07086105 · RECRUITING

Trial details

NCT number: NCT07086105
Sponsor: Adze Biotechnology Australia Pty Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2025-10-01
Primary completion: 2027-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.